Screener
Praxis Precision Medicines, Inc. PRAX Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Praxis Precision Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The source filing: Praxis Precision Medicines, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:32 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001689548-26-000083
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Liabilities and stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable | $23,386 | $24,628 |
| Accrued expenses | 24,585 | 35,033 |
| Operating lease liabilities | 1,087 | 110 |
| Total current liabilities | 49,058 | 59,771 |
| Total liabilities | 49,058 | 59,771 |
| Commitments and contingencies (Note 6) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Praxis Precision Medicines, Inc.'s accrued expenses?
- Praxis Precision Medicines, Inc. (PRAX) reported accrued expenses of $24.59M in Q2 2026.
- How has Praxis Precision Medicines, Inc.'s accrued expenses changed year-over-year?
- Praxis Precision Medicines, Inc.'s accrued expenses increased by 29.3% year-over-year, from $19.02M to $24.59M.
- What is the long-term trend for Praxis Precision Medicines, Inc.'s accrued expenses?
- Over 5 years (2020 to 2025), Praxis Precision Medicines, Inc.'s accrued expenses has grown at a 26.4% compound annual growth rate (CAGR), from $10.87M to $35.03M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.
Ask your AI about Praxis Precision Medicines, Inc.'s accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude